Eberbach, Germany

Klaus Flechsenhar

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Gelita Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Flechsenhar. Retrieved from https://idiyas.com/inventor/klaus-flechsenhar-g79hz3ew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 58(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Flechsenhar: Innovator in Vascular Stent Technology

Introduction

Klaus Flechsenhar is a notable inventor based in Eberbach, Germany. He has made significant contributions to the field of medical devices, particularly in the development of vascular stents. His innovative approach aims to reduce the risk of restenosis, a common complication in vascular interventions.

Latest Patents

Flechsenhar holds a patent for a vascular stent designed to minimize the risk of restenosis without the use of anti-proliferative active substances. The stent features a carrier made of a dimensionally stable material, along with one or more layers composed of a resorbable material based on crosslinked gelatin. This design allows for the neutralization of adhesion between the carrier and the layers, enhancing the stent's effectiveness.

Career Highlights

Throughout his career, Klaus Flechsenhar has been associated with Gelita AG, a company known for its expertise in gelatin-based products. His work has focused on advancing medical technology and improving patient outcomes through innovative solutions.

Collaborations

Flechsenhar has collaborated with notable colleagues, including Michael Ahlers and Steffen Össer. These partnerships have contributed to the development and refinement of his patented technologies.

Conclusion

Klaus Flechsenhar's contributions to vascular stent technology exemplify the impact of innovation in the medical field. His work continues to influence advancements in patient care and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…